Galactica Biotech

AI to accelerate drug repurposing for personalized medicine

Company Details

Galactica Biotech is using a proprietary artificial intelligence-based method to match molecules with new indications for drug repurposing.

  • Pitch Video

Company People

Jorge Valencia

Jorge Valencia
CEO & Founder

Galactica Biotech News


You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision.  Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.